Insight Molecular Diagnostics (IMDX) Consolidated Net Income: 2015-2024
Historic Consolidated Net Income for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to -$61.0 million.
- Insight Molecular Diagnostics' Consolidated Net Income rose 18.25% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 41.10%. This contributed to the annual value of -$61.0 million for FY2024, which is 1986.16% down from last year.
- Insight Molecular Diagnostics' Consolidated Net Income amounted to -$61.0 million in FY2024, which was down 1,986.16% from -$2.9 million recorded in FY2023.
- Insight Molecular Diagnostics' 5-year Consolidated Net Income high stood at -$2.9 million for FY2023, and its period low was -$61.0 million during FY2024.
- Over the past 3 years, Insight Molecular Diagnostics' median Consolidated Net Income value was -$54.3 million (recorded in 2022), while the average stood at -$39.4 million.
- Per our database at Business Quant, Insight Molecular Diagnostics' Consolidated Net Income spiked by 94.61% in 2023 and then slumped by 1,986.16% in 2024.
- Insight Molecular Diagnostics' Consolidated Net Income (Yearly) stood at -$29.9 million in 2020, then soared by 31.45% to -$20.5 million in 2021, then plummeted by 165.00% to -$54.3 million in 2022, then spiked by 94.61% to -$2.9 million in 2023, then tumbled by 1,986.16% to -$61.0 million in 2024.